223 related articles for article (PubMed ID: 34035125)
1. 3,3'-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans.
Vermillion Maier ML; Siddens LK; Uesugi SL; Choi J; Leonard SW; Pennington JM; Tilton SC; Smith JN; Ho E; Chow HHS; Nguyen BD; Kolluri SK; Williams DE
Drug Metab Dispos; 2021 Aug; 49(8):694-705. PubMed ID: 34035125
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice.
Anderton MJ; Manson MM; Verschoyle RD; Gescher A; Lamb JH; Farmer PB; Steward WP; Williams ML
Clin Cancer Res; 2004 Aug; 10(15):5233-41. PubMed ID: 15297427
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM).
Patel AR; Spencer SD; Chougule MB; Safe S; Singh M
Eur J Pharm Sci; 2012 May; 46(1-2):8-16. PubMed ID: 22342559
[TBL] [Abstract][Full Text] [Related]
4. Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in mice.
Anderton MJ; Manson MM; Verschoyle R; Gescher A; Steward WP; Williams ML; Mager DE
Drug Metab Dispos; 2004 Jun; 32(6):632-8. PubMed ID: 15155555
[TBL] [Abstract][Full Text] [Related]
5. Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane.
Williams DE
Front Nutr; 2021; 8():734334. PubMed ID: 34660663
[TBL] [Abstract][Full Text] [Related]
6. Development of a solid-phase extraction method with simple MEKC-UV analysis for simultaneous detection of indole metabolites in human urine after administration of indole dietary supplement.
Phonchai A; Wilairat P; Chantiwas R
Talanta; 2017 Nov; 174():314-319. PubMed ID: 28738586
[TBL] [Abstract][Full Text] [Related]
7. Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane.
Reed GA; Arneson DW; Putnam WC; Smith HJ; Gray JC; Sullivan DK; Mayo MS; Crowell JA; Hurwitz A
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2477-81. PubMed ID: 17164373
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the Power of Cruciferous Vegetables: Developing a Biomarker for Brassica Vegetable Consumption Using Urinary 3,3'-Diindolylmethane.
Fujioka N; Ransom BW; Carmella SG; Upadhyaya P; Lindgren BR; Roper-Batker A; Hatsukami DK; Fritz VA; Rohwer C; Hecht SS
Cancer Prev Res (Phila); 2016 Oct; 9(10):788-793. PubMed ID: 27538743
[TBL] [Abstract][Full Text] [Related]
9. Fate of 3,3'-diindolylmethane in cultured MCF-7 human breast cancer cells.
Staub RE; Onisko B; Bjeldanes LF
Chem Res Toxicol; 2006 Mar; 19(3):436-42. PubMed ID: 16544949
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of 3,3'-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes.
Wu TY; Huang Y; Zhang C; Su ZY; Boyanapalli S; Khor TO; Wang H; Lin H; Gounder M; Kagan L; Androulakis IP; Kong AN
J Pharmacokinet Pharmacodyn; 2015 Aug; 42(4):401-8. PubMed ID: 26138223
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats.
Parkin DR; Lu Y; Bliss RL; Malejka-Giganti D
Food Chem Toxicol; 2008 Jul; 46(7):2451-8. PubMed ID: 18486294
[TBL] [Abstract][Full Text] [Related]
12. 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease.
Tadi K; Chang Y; Ashok BT; Chen Y; Moscatello A; Schaefer SD; Schantz SP; Policastro AJ; Geliebter J; Tiwari RK
Biochem Biophys Res Commun; 2005 Nov; 337(3):1019-25. PubMed ID: 16219298
[TBL] [Abstract][Full Text] [Related]
13. Broccoli-derived phytochemicals indole-3-carbinol and 3,3'-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: comparison with other cancer preventive phytochemicals.
Wang TT; Schoene NW; Milner JA; Kim YS
Mol Carcinog; 2012 Mar; 51(3):244-56. PubMed ID: 21520295
[TBL] [Abstract][Full Text] [Related]
14. Urinary 3,3'-diindolylmethane: a biomarker of glucobrassicin exposure and indole-3-carbinol uptake in humans.
Fujioka N; Ainslie-Waldman CE; Upadhyaya P; Carmella SG; Fritz VA; Rohwer C; Fan Y; Rauch D; Le C; Hatsukami DK; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):282-7. PubMed ID: 24357105
[TBL] [Abstract][Full Text] [Related]
15. Benzo[a]pyrene toxicokinetics in humans following dietary supplementation with 3,3'-diindolylmethane (DIM) or Brussels sprouts.
Vermillion Maier ML; Siddens LK; Pennington JM; Uesugi SL; Tilton SC; Vertel EA; Anderson KA; Tidwell LG; Ognibene TJ; Turteltaub KW; Smith JN; Williams DE
Toxicol Appl Pharmacol; 2023 Feb; 460():116377. PubMed ID: 36642108
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane.
Chen I; McDougal A; Wang F; Safe S
Carcinogenesis; 1998 Sep; 19(9):1631-9. PubMed ID: 9771935
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.
Banerjee S; Kong D; Wang Z; Bao B; Hillman GG; Sarkar FH
Mutat Res; 2011; 728(1-2):47-66. PubMed ID: 21703360
[TBL] [Abstract][Full Text] [Related]
18. A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals.
Minich DM; Bland JS
Nutr Rev; 2007 Jun; 65(6 Pt 1):259-67. PubMed ID: 17605302
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats.
Stresser DM; Williams DE; Griffin DA; Bailey GS
Drug Metab Dispos; 1995 Sep; 23(9):965-75. PubMed ID: 8565787
[TBL] [Abstract][Full Text] [Related]
20. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
Thomson CA; Chow HHS; Wertheim BC; Roe DJ; Stopeck A; Maskarinec G; Altbach M; Chalasani P; Huang C; Strom MB; Galons JP; Thompson PA
Breast Cancer Res Treat; 2017 Aug; 165(1):97-107. PubMed ID: 28560655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
